["Catecholamine refractory" cardiogenic shock? "Bridging-to-recovery" by implantation of a percutaneous cardiac assist device].
Use of Percutaneous Left Ventricular Assist Device Before Durable Device Implantation in Patients With Cardiac Cachexia: Case Series.
Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
Saito S, Okubo S, Matsuoka T, Hirota S, Yokoyama S, Kanazawa Y, Takei Y, Tezuka M, Tsuchiya G, Konishi T, Shibasaki I, Ogata K, Fukuda H.
J Cardiol. 2024 Apr;83(4):228-235. doi: 10.1016/j.jjcc.2023.10.008. Epub 2023 Nov 4.
A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, Dirschinger J, Kastrati A, Schömig A.
J Am Coll Cardiol. 2008 Nov 4;52(19):1584-8. doi: 10.1016/j.jacc.2008.05.065.
Use of Percutaneous Left Ventricular Assist Device Before Durable Device Implantation in Patients With Cardiac Cachexia: Case Series.
Salas De Armas IA, Bergeron A, Akkanti B, Akay MH, Scovell A, Patel MK, Patel J, Bhardwaj A, Al Rameni D, Marcano J, Nascimbene A, Kar B, Gregoric ID.
ASAIO J. 2023 Jul 1;69(7):e354-e359. doi: 10.1097/MAT.0000000000001902. Epub 2023 Apr 10.
Total percutaneous biventricular assist device implantation for fulminant myocarditis.
Tominaga Y, Toda K, Miyagawa S, Yoshioka D, Kainuma S, Kawamura T, Kawamura A, Nakamoto K, Sakata Y, Sawa Y.
J Artif Organs. 2021 Jun;24(2):254-257. doi: 10.1007/s10047-020-01197-6. Epub 2020 Aug 4.
Percutaneous, minimally invasive approach to implantable left ventricular assist device deactivation.
Kidambi S, Shudo Y, Dake MD, Woo YJ, Ha RV.
J Thorac Cardiovasc Surg. 2018 Feb;155(2):653-654. doi: 10.1016/j.jtcvs.2017.08.120. Epub 2017 Sep 13.
Concurrent Left Ventricular Assist Device (LVAD) Implantation and Percutaneous Temporary RVAD Support via CardiacAssist Protek-Duo TandemHeart to Preempt Right Heart Failure.
Schmack B, Weymann A, Popov AF, Patil NP, Sabashnikov A, Kremer J, Farag M, Brcic A, Lichtenstern C, Karck M, Ruhparwar A.
Med Sci Monit Basic Res. 2016 May 5;22:53-7. doi: 10.12659/MSMBR.898897.
Cerebral protection during percutaneous intervention for left ventricular assist device outflow graft obstruction.
Joury A, Patel RAG, Wever-Pinzon J, Eiswirth C, Desai S, Bansal A, Krim SR.
Catheter Cardiovasc Interv. 2022 Aug;100(2):266-273. doi: 10.1002/ccd.30241. Epub 2022 May 25.
Impella percutaneous left ventricular assist device as mechanical circulatory support for cardiogenic shock: A retrospective analysis from a tertiary academic medical center.
Nouri SN, Malick W, Masoumi A, Fried JA, Topkara VK, Brener MI, Ahmad Y, Prasad M, Rabbani LE, Takeda K, Karmpaliotis D, Moses JW, Leon MB, Kirtane AJ, Garan AR.
Catheter Cardiovasc Interv. 2022 Jan 1;99(1):37-47. doi: 10.1002/ccd.29434. Epub 2020 Dec 16.
Percutaneous Driveline Fracture After Implantation of the HeartMate II Left Ventricular Assist Device: How Durable is Driveline Repair?
Stulak JM, Schettle S, Haglund N, Dunlay S, Cowger J, Shah P, Aaronson KD, Pagani FD, Maltais S.
ASAIO J. 2017 Sep/Oct;63(5):542-545. doi: 10.1097/MAT.0000000000000531.
Noteworthy Cardiac Surgical Literature 2018: Value-Based Bundled Payments, Opioid Crisis and Cardiac Surgery, Percutaneous Suction Thrombectomy for Intracardiac/Caval Thrombus and Vegetations, and Minimally Invasive Left Ventricular Assist Device Placement.
Aftab M, Reece TB, Cleveland JC, Pal JD.
Semin Cardiothorac Vasc Anesth. 2019 Jun;23(2):164-170. doi: 10.1177/1089253219845417.
